|1 to 10 of 619||Next||Last|
The House Energy and Commerce subcommittee on health has scheduled a hearing for Wednesday, March 22, at 10:15 a.m. ET, in room 2322 of the Rayburn House Office Building, Washington, DC. The hearing is titled, “Examining FDA’s Prescription Drug User Fee Program.”
The Senate voted 55-43 on Monday (March 13) to approve Seema Verma’s appointment as administrator of the Centers for Medicare and Medicaid Services. Verma's confirmation comes as congressional Republicans continue pressing to repeal and replace Obamacare, an overhaul that would require considerable involvement from CMS. The health care bill making its way through the House currently plans to eliminate Medicaid expansion after 2020.
This week, House Republicans released the text of legislation that will "repeal and replace" the Affordable Care Act (often referred to as the ACA or Obamacare). The bill’s release was met with both praise and criticism.
Dubbed the American Health Care Act, the 123-page bill surfaced Monday night, with House Republican leaders promising to begin marking it up as early as Wednesday (March 8) in two committees, even though very few House Republicans had a chance to review the measure prior to its release. Indeed, the Congressional Budget Office hasn’t yet issued its assessment of the bill's cost and impact on coverage levels.
The House Energy and Commerce subcommittee on Health, chaired by Rep. Michael Burgess, M.D. (R-TX), held a hearing Thursday examining the Generic Drug User Fee Amendments of 2012 (GDUFA) and the Biosimilar User Fee Act of 2012 (BsUFA), both of which expire in September and must be reauthorized for the Fiscal Years 2018-2022. Also discussed during the hearing was legislation introduced by Reps. Gus Bilirakis (R-FL) and Kurt Schrader (D-OR) -- HR 749, the proposed Lower Costs Through Competition Act.
According to the Government Accountability Office, financial fraud targeting older Americans costs an estimated $2.9 billion annually. This bipartisan legislation would put in place a commonsense plan to protect older Americans from financial exploitation by providing support to regulators, financial institutions, and legal organizations to educate their employees to identify and prevent financial exploitation of older Americans.
The new legislation would instruct the Secretary of Health and Human Services to issue regulations allowing the importation of qualifying prescription drugs from Canada.
The bill is aimed at improving the access Medicare beneficiaries have to home health care by allowing physician assistants, nurse practitioners, clinical nurse specialists, and certified nurse midwives to order home health services, all of which are playing increasingly important roles in the delivery of health care, particularly in rural and underserved areas of our nation.
The bill would put in place a plan to help protect American seniors from financial exploitation and fraud by providing support to regulators, financial institutions, and legal organizations aimed at educating their employees about how to identify and prevent financial exploitation of older Americans.
Sen. Susan Collins (R-ME) and Amy Klobuchar (D-MN) have introduced a bipartisan Senate Resolution declaring that the goal of preventing and effectively treating Alzheimer’s by 2025 is an “urgent national priority.” The resolution calls on the Senate to double the amount of funding the government spends on Alzheimer’s in fiscal year 2017 and develop a plan to meet the target of $2 billion per year in funding, as recommended by experts to meet the goal of preventing and effectively treating Alzheimer’s by 2025.
|1 to 10 of 619||Next||Last|